SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-23-003687
Filing Date
2023-03-28
Accepted
2023-03-28 10:11:54
Documents
7
Period of Report
2023-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K evo_6k.htm 6-K 10572
2 EVOTEC AND BRISTOL MYERS SQUIBB EXPAND STRATEGIC NEURODEGENERATION PARTNERSHIP evo_ex991.htm EX-99.1 3076
3 EVOTEC AND BRISTOL MYERS SQUIBB EXTEND AND EXPAND STRATEGIC NEURODEGENERATION PA evo_ex992.htm EX-99.2 2369
4 evo_ex991img1.jpg GRAPHIC 2790
5 evo_ex992img1.jpg GRAPHIC 211120
6 evo_ex992img2.jpg GRAPHIC 238732
7 evo_ex992img3.jpg GRAPHIC 47369
  Complete submission text file 0001654954-23-003687.txt   706180
Mailing Address ESSENER BOGEN 7 HAMBURG 2M 22419
Business Address ESSENER BOGEN 7 HAMBURG 2M 22419 49-40-560-810
Evotec SE (Filer) CIK: 0001412558 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34041 | Film No.: 23766762
SIC: 2834 Pharmaceutical Preparations